Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

LivaNova PLC (LIVN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
64.57+2.19 (+3.51%)
At close: 04:00PM EDT
64.57 0.00 (0.00%)
After hours: 05:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close62.38
Open62.90
Bid64.52 x 1100
Ask103.31 x 1300
Day's Range62.45 - 64.65
52 Week Range56.13 - 93.89
Volume531,149
Avg. Volume367,396
Market Cap3.451B
Beta (5Y Monthly)0.91
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for LIVN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • LivaNova PLC
    Analyst Report: LivaNova PLCU.K.-based LivaNova was born of a combination between Cyberonics in the U.S. and Sorin in Italy. The medical device firm is primarily focused on cardiovascular and cardiopulmonary solutions (with surgical heart valves, heart-lung machines, and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management segment. LivaNova derives roughly half of its revenue from the U.S. market, another 21% from Europe, and the remainder from the rest of the world.
    Rating
    Fair Value
    Economic Moat
    2 days agoMorningstar
View more
  • Simply Wall St.

    Is LivaNova PLC (NASDAQ:LIVN) Potentially Undervalued?

    LivaNova PLC ( NASDAQ:LIVN ), might not be a large cap stock, but it received a lot of attention from a substantial...

  • Simply Wall St.

    LivaNova's (NASDAQ:LIVN) Returns On Capital Not Reflecting Well On The Business

    When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...

  • American City Business Journals

    ALung acquired by London-based health care company

    ALung Technologies Inc., whose HemoLung product developed out of the University of Pittsburgh helps patients with acute respiratory distress, has been acquired by a London-based medical technology company. LivaNova (NASDAQ: LIVN) acquired ALung for $10 million with additional payments on sales-based milestones in the future, according to LivaNova's first-quarter earnings report that was released Wednesday. "ALung products are complementary to LivaNova's ACS portfolio and, as such, the business and financial results will be included in the company's ACS (Advanced Circulatory Support) segment," LivaNova said.

Advertisement
Advertisement